Bret Jensen

|RSS

Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

By

Bret Jensen

 | May 21, 2017 | 10:00 AM EDT
But home builders continue to construct a strong story.
By

Bret Jensen

 | May 19, 2017 | 11:30 AM EDT
But home builders continue to construct a strong story.
By

Bret Jensen

 | May 17, 2017 | 11:30 AM EDT
These stocks will be great stories in the second half of 2017, and are significantly undervalued.
By

Bret Jensen

 | May 15, 2017 | 1:00 PM EDT
Three names show how fast biotechs can become oversold when the market acts in knee-jerk fashion.
RMPIA
By

Bret Jensen

 | May 14, 2017 | 10:00 AM EDT
These names are now undervalued, despite solid results and good fundamentals.
RMPIA
By

Bret Jensen

 | May 12, 2017 | 11:30 AM EDT
These names are now undervalued, despite solid results and good fundamentals.
By

Bret Jensen

 | May 10, 2017 | 11:30 AM EDT
Homebuilders are the second-largest allocation within my biotech.
By

Bret Jensen

 | May 8, 2017 | 11:30 AM EDT
Worries are increasing around the industry, though Visteon remains a stock to watch.
By

Bret Jensen

 | May 5, 2017 | 1:00 PM EDT
Readers have asked about these three small biotechs that have seen their share prices droop lately.
RMPIA
By

Bret Jensen

 | May 3, 2017 | 11:40 AM EDT
How did Celgene, AbbVie and Gilead fare last quarter?

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.